The Business Times
SUBSCRIBERS

Taking a new path in pain management (Amended)

iX Biopharma wants to be the first in the world to get ketamine registered in the US as an alternative to opioid - the only pain management drug administered by doctors.

google-preferred-sourceAdd BT as a preferred source
Published Sun, Jul 19, 2015 · 09:50 PM

    Singapore

    WITH one day to go before it trades on the Catalist, late-stage specialty pharmaceutical firm iX Biopharma has already caught the eyes of interested parties.

    This might have something to do with the firm's niche, which lies in the development and commercialisation of innovative therapies for pain management and male erectile dysfunction.

    iX Biopharma

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More